Impact of time-to-treatment on survival for advanced non-small cell lung cancer patients in the Netherlands: a nationwide observational cohort study
Conclusion
Although in general it is important to start treatment as early as possible, our study finds no evidence that a more rapid start of treatment improves outcomes in advanced stage NSCLC patients. The benefit of urgent treatment is probably confounded by unmeasured patient and tumour characteristics and, clinical urgency dictating timelines of treatment. Time-to-treatment and its impact should be continuously evaluated as therapeutic strategies continue to evolve and improve.
Source: Thorax - Category: Respiratory Medicine Authors: Klarenbeek, S. E., Aarts, M. J., van den Heuvel, M. M., Prokop, M., Tummers, M., Schuurbiers, O. C. J. Tags: Editor's choice, Thorax Lung cancer Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Immunotherapy | Lung Cancer | Netherlands Health | Non-Small Cell Lung Cancer | Respiratory Medicine | Study